 |
Technical Data |
|
I8430-10J |
IL8, Recombinant, Human, Western Blot Control (Interleukin-8, IL-8, C-X-C Motif Chemokine 8, Monocyte-derived Neutrophil Chemotactic Factor, MDNCF, T-cell Chemotactic Factor, Neutrophil-activating Protein 1, NAP-1, Protein 3-10C, Granulocyte Chemotactic P |
10ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
Interleukin-8 (IL-8) belongs to the neutrophil-specific CXC family of chemokines. It is one of the initial cytokines released from a variety of cell types, including T cells, endothelial cells and fibroblasts, in response to an inflammatory stimulus and acts by recruiting neutrophils, T-cells and basophils to the site of inflammation. Elevated Interleukin-8 levels are associated with the onset of a variety of disease states. Source: Recombinant corresponding to aa23-99 from mature human IL-8, fused to 6x His-tag at N-terminal, expressed in E. coli. Applications: Suitable for use in Western Blot as a control. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
Source: E. coli Purity: Purified (SDS-PAGE) Concentration: As reported Form: Supplied as a liquid in 25mM Tris-HCl, pH6.8, 50mM DTT, 1% SDS, 0.1% Bromophenol Blue, 2.5% glycerol. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Baggiolini, M & Clark-Lewis I (1992) FEBS Letters 307 (1): 97-101.
|
||